subscribeSubscribe
FDA denies hearing to Vanda on jet lag indication for sleep disorder drug

FDA denies hearing to Vanda on jet lag indication for sleep disorder drug
ENDPTS
06 Mar 2024
Share Share
Vanda takes issue with FDA`s relay of deficiencies for new Hetlioz indication

Vanda takes issue with FDA`s relay of deficiencies for new Hetlioz indication
ENDPTS
05 Feb 2024
Share Share
Vanda Pharmaceuticals Responds to Ruling in HETLIOZ® ANDA Appeal

Vanda Pharmaceuticals Responds to Ruling in HETLIOZ® ANDA Appeal
PR NEWSWIRE
10 May 2023
Share Share
Vanda Prevails in Jet Lag Litigation Against the FDA

Vanda Prevails in Jet Lag Litigation Against the FDA
PR NEWSWIRE
29 Mar 2023
Share Share
MSN`s Generic Tasimelteon Receives Approval in the U.S.

MSN`s Generic Tasimelteon Receives Approval in the U.S.
FDA
12 Jan 2023
Share Share
Apotex`s Generic Tasimelteon Receives Approval in the U.S.

Apotex`s Generic Tasimelteon Receives Approval in the U.S.
FDA
20 Dec 2022
Share Share
Teva, Apotex prevail over Vanda in patent infringement case

Teva, Apotex prevail over Vanda in patent infringement case
Kevin Dunleavy FIERCEPHARMA
15 Dec 2022
Share Share
Teva`s Generic Tasimelteon Receives Approval in the U.S.

Teva`s Generic Tasimelteon Receives Approval in the U.S.
FDA
12 Dec 2022
Share Share
CDER strikes back at Vanda, discloses rationale behind 2019 sNDA rejection

CDER strikes back at Vanda, discloses rationale behind 2019 sNDA rejection
Paul Schloesser ENDPTS
10 Oct 2022
Share Share
Vanda Announces Notice of Opportunity For An FDA Hearing on the sNDA

Vanda Announces Notice of Opportunity For An FDA Hearing on the sNDA
PRNEWSWIRE
07 Sep 2022
Share Share